NASDAQ:INBX | Balance Sheet | Inhibrx Biosciences, Inc.

Complete source-backed balance-sheet history.

Available history
2022-12-31 to 2026-06-30
Data captured

Historical Balance Sheet

DateCash and equivalentsCurrent securitiesReceivablesInventoryOther current assetsCurrent assetsProperty, plant and equipmentOther noncurrent assetsTotal assetsAccounts payableCurrent liabilitiesLong-term debtOther noncurrent liabilitiesTotal liabilitiesShareholder equity
2026-06-30$133.34M$574,000.00$142.21M$2.69M$4.77M$154.22M$9.8M$28.06M$207.2M-$52.98M
2026-03-31$161.66M$262,000.00$171.34M$3.2M$4.38M$183.97M$8.76M$26.51M$205M-$21.04M
2025-12-31$124.22M$238,000.00$132.83M$3.73M$4.38M$146.48M$5.94M$33.8M$138.49M$7.99M
2025-09-30$153.09M$410,000.00$161.42M$4.31M$5.74M$177.47M$6.77M$35.98M$140.64M$36.83M
2025-06-30$186.57M$283,000.00$193.96M$4.89M$6.81M$212.12M$8.29M$38.94M$143.56M$68.56M
2025-03-31$216.52M$269,000.00$223.39M$5.55M$6.8M$242.64M$8.89M$43.64M$148.2M$94.44M
2024-12-31$152.6M$382,000.00$160.4M$6.2M$6.83M$180.77M$9.25M$40.73M$47.18M$133.58M
2024-09-30$196.33M$748,000.00$207.45M$6.88M$6.71M$222.56M$12.37M$44.1M$44.1M$178.47M
2024-06-30$226.86M$966,000.00$242.06M$7.61M$6.75M$258.42M$13.02M$39.05M$39.05M$219.37M
2024-03-31$252.48M$11.57M
2023-12-31$277.92M$366,000.00$295.36M$6.42M$3.16M$307.89M$10.95M$56.31M$264.39M$43.5M
2023-09-30$337.33M$129.6M
2023-06-30$192.49M-$24.81M
2023-03-31$15.13M
2022-12-31$273.87M$58.06M